Minerva Neurosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. 

CEO
Rémy Henri Luthringer
CEORémy Henri Luthringer
Employees
9
Employees9
Headquarters
Burlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded
2007
Founded2007
Employees
9
Employees9

NERV Key Statistics

Market cap
17.62M
Market cap17.62M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
—
Dividend yield—
Average volume
19.24K
Average volume19.24K
High today
$2.53
High today$2.53
Low today
$2.47
Low today$2.47
Open price
$2.53
Open price$2.53
Volume
3.79K
Volume3.79K
52 Week high
$13.49
52 Week high$13.49
52 Week low
$2.26
52 Week low$2.26
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.